Literature DB >> 9381360

[Intracavitary afterloading therapy as a new technique of boost irradiation in anal canal carcinoma].

O Kölbl1, K Bratengeier, S Richter, R Henkel, R Schmidt, M Flentje.   

Abstract

PURPOSE: There are different techniques of boost irradiation in the treatment of patients with anal carcinoma. A new system of applicators is presented, which can be used for an intracavitary afterloading therapy.
MATERIAL AND METHODS: Three different applicators are available, the first with a central catheter (K1), a second with 5 semicircular fixed catheters (K2) and an eccentric shield, a third with 8 circular fixed catheters and a central shield (K3).
RESULTS: The adequate choice of applicator and catheters takes into consideration the individual localisation and extension of anal carcinoma in planning therapy. Thus, in circular growing tumors, an irradiation of the whole circumference of the anal canal is possible. In non-circular growing tumors, the dose applied in the non-affected part of the anal canal can be reduced to a quarter of the dose applied at the tumor.
CONCLUSION: The new system of intracavitary afterloading therapy is a good alternative to previous techniques of boost irradiation in the treatment of anal carcinoma. By means of this technique, irradiation can be highly individualized, the tumor better included and non-affected sections of the anal canal saved.

Entities:  

Mesh:

Year:  1997        PMID: 9381360     DOI: 10.1007/bf03038467

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  17 in total

1.  Cancer of the anal canal: report on the experience of 61 patients.

Authors:  J B Dubois; J M Garrigues; H Pujol
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-03       Impact factor: 7.038

2.  Feasibility of non-surgical definitive management of anal canal carcinoma.

Authors:  M J John; M Flam; L Lovalvo; P A Mowry
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-03       Impact factor: 7.038

3.  Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy.

Authors:  B Cummings; T Keane; G Thomas; A Harwood; W Rider
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

4.  Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity.

Authors:  G Tanum; K Tveit; K O Karlsen; M Hauer-Jensen
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

5.  Interstitial curietherapy in the conservative treatment of anal and rectal cancers.

Authors:  J Papillon; J F Montbarbon; J P Gerard; J L Chassard; J M Ardiet
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

6.  Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

Authors:  B J Cummings; T J Keane; B O'Sullivan; C S Wong; C N Catton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

7.  Epidermoid carcinoma of the anal canal. A series of 276 cases.

Authors:  J Papillon; J F Montbarbon
Journal:  Dis Colon Rectum       Date:  1987-05       Impact factor: 4.585

8.  Squamous cell carcinoma of the anal canal: treatment by external beam irradiation.

Authors:  F Eschwege; P Lasser; A Chavy; P Wibault; J Kac; P Rougier; C Bognel
Journal:  Radiother Oncol       Date:  1985-02       Impact factor: 6.280

9.  Review of recent experience in the treatment of carcinoma of the anal canal.

Authors:  M Ajlouni; D Mahrt; M P Milad
Journal:  Am J Clin Oncol       Date:  1984-12       Impact factor: 2.339

10.  A new approach to the management of epidermoid carcinoma of the anal canal.

Authors:  J Papillon; M Mayer; J F Montbarbon; J P Gerard; J L Chassard; C Bailly
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.